Trial Profile
A dose proportionality and safety study of Diazepam Buccal Soluble Film (Diazepam BSF) for the treatment of Acute Repetitive Seizures (ARS)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2018
Price :
$35
*
At a glance
- Drugs Diazepam (Primary)
- Indications Epilepsy; Seizures
- Focus Adverse reactions; Pharmacokinetics
- 27 Apr 2018 Results presented at the 70th Annual Meeting of the American Academy of Neurology
- 16 Mar 2018 New trial record